GT Biopharma, Inc. (GTBP) research
GT Biopharma, Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $8.61
- As of
Share the GTBP intelligence card
See GTBP live in the terminal
Track GTBP's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live GTBP terminal, freeActive signals for GTBP
- mediumEARNINGS_MISS
Q2-2026: Missed consensus by 47.1%, EPS $-0.12 vs $-0.0816 estimate
- mediumEARNINGS_BEAT
Q2-2025: Beat consensus by 25.0% - EPS $-0.52 vs $-0.6936 estimate
- mediumEARNINGS_MISS
Q3-2025: Missed consensus by 103.8% - EPS $-0.79 vs $-0.3876 estimate
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 2056.9% - EPS $-4.84 vs $-0.2244 estimate
- mediumEARNINGS_MISS
Q1-2026: Missed consensus by 34.8% - EPS $-0.11 vs $-0.0816 estimate
FREE, NO ACCOUNT
Every signal on GTBP, as it fires
New filings, 13F moves and cross asset signals on GTBP land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, GTBP
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
See more GTBP signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to GTBPand get the insider, 13F, options, and confluence read in one view.